New study using TAmiRNAs SARS-CoV-2 Antibody Test (Lateral Flow Method)

The aims of the study was to determine:

(i) SARS-CoV-2 antibody positive employees in Austrian trauma hospitals and rehabilitation facilities,

(ii) number of active virus carriers (symptomatic and asymptomatic) during the study

(iii) antibody decline in seropositive subjects over a period of around 6 months and

(iv) the usefulness of rapid antibody tests for outpatient screening.

To find out more about TAmiRNAs SARS-CoV-2 Antibody Test (Lateral Flow Method) click HERE